CORAR Announces its Next Executive Director

September 12, 2011

CORAR Announces its Next Executive Director

The Council of Radionculides and Radiopharmaceuticals (CORAR) announced the selection of Michael Guastella as its next Executive Director in succession to the retiring Henry H. Kramer, Ph.D., FACNP, the founding Executive Director of CORAR. Michael has 18 years of work experience with both Syncor International Corporation and Cardinal Health and most recently, was the VP of Marketing and Product Development for the Nuclear Pharmacy Business of Cardinal Health.

To view the CORAR press release, please see the attached.

CORAR Press Release Announcing its Next Executive Director